Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Ethinylestradiol/norethisterone acetate
Combination of | |
---|---|
Ethinylestradiol | Estrogen |
Norethisterone acetate | Progestogen |
Clinical data | |
Trade names | Estrostep, FemHRT, Loestrin, Microgestin, others |
Other names | EE/NETA |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Routes of administration |
By mouth (pill) |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
3D model (JSmol) | |
| |
|
Ethinylestradiol/norethisterone acetate (EE/NETA), or ethinylestradiol/norethindrone acetate, is a combination of ethinylestradiol (EE) and norethisterone acetate (NETA) which is used as birth control and menopausal hormone therapy. EE is an estrogen, while norethisterone acetate (NETA) is a progestin. It is taken by mouth. Some preparations of EE/NETA used in birth control additionally contain an iron supplement in the form of ferrous fumarate.
In 2020, it was the 45th most commonly prescribed medication in the United States, with more than 14 million prescriptions. It is available as a generic medication.
Society and culture
Brand names
Brand names of EE/NETA include Anovlar, Blisovi, Cumorit, Estrostep, FemHRT, Fyavolv, Gildess, Junel, Larin, Leribane, Loestrin, Lo Loestrin (Lo Lo), Mibelas, Microgestin, Minastrin, Norlestrin, Primodos, Taytulla, and Tri-Legest, among others.
In addition, the combination is sold in the United States under the brand name FemHRT for use in menopausal hormone therapy.
See also
- Estradiol/norethisterone acetate
- Oral contraceptive formulations
- List of combined sex-hormonal preparations
- Nand Peeters
External links
- "Ethinyl estradiol mixture with norethindrone acetate". Drug Information Portal. U.S. National Library of Medicine.
Comparison | |||||
---|---|---|---|---|---|
Behavioral |
|
||||
Barrier and / or spermicidal | |||||
Hormonal (formulations) |
|
||||
Anti-estrogen |
|
||||
Post-intercourse | |||||
Intrauterine device | |||||
Sterilization |
|
||||
Experimental | |||||
Long-acting reversible contraception (LARC) |
Androgens | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Estrogens | |||||||||||||
Progestogens |
|
PR |
|
||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
|
||||||